House resolution · 119th Congress · Latest step: Introduced
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Sponsor: Rep. John Rose R-TNWhere it went
- IntroducedOct 10, 2025
- Committee action—
- Passed House—
Latest action: Oct 10, 2025 — Referred to the House Committee on Energy and Commerce.
Vote results
No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).
Cosponsors
11 cosponsors — 11 Republicans
0 of 11 cosponsors (0%) are from the other party.
Robert Aderholt (R-AL), Sheri Biggs (R-SC), Earl Carter (R-GA), Ben Cline (R-VA), Glenn Grothman (R-WI), Michael Guest (R-MS), Harriet Hageman (R-WY), Andy Harris (R-MD), Diana Harshbarger (R-TN), Doug LaMalfa (R-CA), Barry Moore (R-AL).
More from the sponsor
Other 119th Congress bills sponsored by Rep. John Rose.
- H.R. 2808 (119th) Homebuyers Privacy Protection Act
- H.R. 2462 (119th) Black Vulture Relief Act
- H.R. 1138 (119th) Payment Choice Act of 2025
- H.R. 1631 (119th) Safe Access to Cash Act of 2025
- H.R. 6293 (119th) Housing Supply Expansion Act of 2025
- H.R. 10478 (119th) Aid and Attendance Assistance for Veterans Act
Sponsor’s state and district
Data as of Sep 13, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.